Health and Pharmaceutical News
Today's News …
|
How investors use this site to find stocks on the move.
|
Drug-resistant
TB killed 150000 in 2008 2:37 PM 3/18/2010
Reuters
Multiple drug-resistant tuberculosis (MDR-TB) killed 150,000 in 2008 and infects between 400,000 and 500,000 globally. MDR-TB is more common in Russia, Tajikistan, China, and India.
...
See all stories on this topic
EU
approves Novartis' meningoccal vaccine 5:06 AM 3/18/2010
Reuters
Novartis' key meningococcal vaccine Menveo has been approved in Europe.
...
See all stories on this topic
How
common are stolen prescription drugs, and where does the contraband
resurface? 3:51 AM 3/18/2010
Newsweek
The most common route is down to Miami-Dade Florida and on to Latin America. Some repackaged and reintroduced into the US market.
...
See all stories on this topic
Abraxis
Flies On Drug Test Success 2:26 PM 3/17/2010
Forbes
Abraxis BioScience announced that its lung cancer treatment Abraxane passed a successful late-stage test comparing Abraxane (protein-bound paclitaxel) with Taxol (paclitaxel) injections.
...
See all stories on this topic
Thieves
grab up to $75 million in Eli Lilly drugs 6:56 AM 3/17/2010
Reuters
As much as $75 million in popular Eli Lilly & Co prescription drugs including Prozac were stolen during a raging storm from a Connecticut warehouse.
...
See all stories on this topic
Breast
cancer study aims to speed drugs, cooperation 5:23 AM 3/17/2010
Reuters
The Investigation of Serial Studies to Predict your Therapeutic Response with Imaging and Molecular Analysis (I-SPY2) study will use DNA to match the best drug to each individual patient.
...
See all stories on this topic
Novartis
drug no help after heart attack-study 1:05 PM 3/16/2010
Reuters
The addition of the Novartis blood pressure drug Tekturna to current standard drugs used to treat patients who had a heart attack failed to help.
...
See all stories on this topic
Long-term
safety of drug-coated stents questioned 12:35 PM 3/16/2010
Reuters
Patients who got drug-coated stents right after suffering a severe heart attack later died from heart-related problems more frequently than those who received older cheaper bare-metal stents.
...
See all stories on this topic
BioTime
Shares Surge After Demonstrating Age-Reversal Process 11:44 AM 3/16/2010
BusinessWeek
BioTime Inc develops stem cell products. BioTime’s technology for genetic modification may work to reverse aging.
...
See all stories on this topic
Dynavax
gets going-concern warning 10:30 AM 3/16/2010
Reuters
Dynavax Technologies Corp said its auditors have expressed doubts on the company's ability to stay afloat. The company still plans to submit a regulatory application for its experimental hepatitis B vaccine Heplisav.
...
See all stories on this topic
Arthritis
drug shows promise in Type 2 diabetes study 4:07 AM 3/16/2010
Boston Globe
Salsalate is being studied as a potential treatment for repeat heart attacks and to stall development of Type 2 diabetes.
...
See all stories on this topic
Adding
fat-lowering drug no help for diabetic hearts 5:25 PM 3/15/2010
Reuters
Combining a drug that lowers triglycerides with cholesterol-fighting statins provided no additional protection from heart attack, stroke, and death from heart disease in patients with Type 2 diabetes.
...
See all stories on this topic
GTx
ends Merck partnership, regains muscle drug 4:45 PM 3/15/2010
Forbes
GTx Inc ended a collaboration with German drug maker Merck on drug candidate ostarine intended to treat muscle loss in cancer patients.
...
See all stories on this topic
FDA
Grinds MannKind On Diabetes Drug 1:52 PM 3/15/2010
Forbes
The US FDA is concerned about MannKind Corp's Afrezza clinical utility as an inhaled insulin medicine intended to treat diabetes.
...
See all stories on this topic
Medtronic
atrial fibrillation system shines in study 9:48 AM 3/15/2010
Reuters
Medtronic Inc's cryoablation system that freezes and kills problem-causing heart tissue was nearly 10 times better at eliminating a potentially serious heart rhythm disorder than conventional anti-arrhythmic drugs.
...
See all stories on this topic
Merck,
Portola's Anti-Clotting Drug Linked to Less Bleeding 9:40 AM 3/15/2010
BusinessWeek
Merck & Co and Portola Pharmaceuticals Inc announced that experimental anti-clotting drug betrixaban caused less bleeding than warfarin.
...
See all stories on this topic
BioSante's
pancreatic cancer vaccine gets orphan status 7:58 AM 3/15/2010
Reuters
BioSante Pharmaceuticals Inc's experimental pancreatic cancer vaccine GVAX was granted orphan drug status by the US FDA.
...
See all stories on this topic
Inspire
Pharma eye drug fails in mid-stage study 6:21 AM 3/15/2010
Reuters
Inspire Pharmaceuticals Inc's experimental eye drug Azasite failed to meet the main goals of two mid-stage trials in patients with anterior blepharitis.
...
See all stories on this topic
FDA
denies approval of Amylin, Lilly diabetes drug 6:01 AM 3/15/2010
Reuters
The US FDA did not immediately approve Amylin Pharmaceuticals Inc's once-weekly form of its diabetes drug Byetta nor did they ask for lengthy new clinical trials.
...
See all stories on this topic
Novartis
drugs fail to help high-risk patients 6:18 AM 3/14/2010
Reuters
Novartis diabetes drug Starlix (nateglinide) failed to reduce progression of diabetes or cut down on serious heart problems in patients at high risk for heart disease.
...
See all stories on this topic
Teva
Sues Mylan Over Generic of Birth-Control Drugs 4:49 AM 3/13/2010
BusinessWeek
Teva Pharmaceutical Industries sued to prevent Mylan Inc from selling copies of the LoSeasonique and Seasonique (ethinyl estradiol and levonorgestrel) birth-control pills. The patents expire in 2023 and 2024.
...
See all stories on this topic
US
court rules again against vaccine-autism claims 4:03 PM 3/12/2010
Reuters
Vaccines that contain mercury-based preservative thimerosal cannot cause autism on their own.
...
See all stories on this topic
Ligand,
Glaxo drug gets European approval 1:19 PM 3/12/2010
The Associated Press
Ligand Pharmaceuticals Inc's partner GlaxoSmithKline gained European regulatory approval to sell the blood disorder drug Revolade.
...
See all stories on this topic
Azur
to acquire Elan's painkiller Prialt 12:07 PM 3/11/2010
Reuters
Azur Pharma Limited entered into a definitive agreement with Elan Pharmaceuticals Inc to buy its painkiller Prialt (ziconotide).
...
See all stories on this topic
Bayer
lung infection drug gets orphan status 10:19 AM 3/11/2010
Forbes
Bayer HealthCare Pharmaceuticals received US FDA orphan status for an inhaled drug intended to treat lung infections in cystic fibrosis patients. The drug also has orphan status in the European Union.
...
See all stories on this topic
Astra
boosts emerging markets with generics deal 5:07 AM 3/11/2010
Reuters
AstraZeneca expands in emerging markets through a branded generics supply deal with Indian group Torrent Pharmaceuticals.
...
See all stories on this topic
Abbott
Tucks In Facet Biotech 3:57 PM 3/10/2010
Forbes
Abbott Laboratories will pay $27 per share for Facet Biotech.
...
See all stories on this topic
Watson,
Takeda resolve Actos patent litigation 7:57 AM 3/10/2010
Reuters
Japan's Takeda Pharmaceutical Co granted Watson Pharmaceuticals Inc a non-exclusive royalty-free license to its US patents covering Actos and gave Watson permission to launch its generic equivalent version of Actos on August 17, 2012.
...
See all stories on this topic
Novartis
takes option on Transgene cancer vaccine 6:01 AM 3/10/2010
Reuters
Novartis took an exclusive option to develop Transgene's cancer vaccine TG4010.
...
See all stories on this topic
US
FDA panel backs InterMune lung drug 1:58 PM 3/9/2010
Reuters
US FDA advisers backed InterMune Inc's experimental drug pirfenidone to treat lung scarring for patients with idiopathic pulmonary fibrosis (IPF).
...
See all stories on this topic
Amylin,
Lilly Diabetes Drug Faces Crucial FDA Decision 1:08 PM 3/9/2010
Wall Street Journal
Long-acting diabetes drug Byetta LAR is vital to Amylin's growth.
...
See all stories on this topic
<- Earlier Stories | Topics Recently In the News
See All
  
Archived News…
This engine looks for content moved to the archive. Place exact phrases within quotes.
Use Google…
|
